LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Jennifer Jackson, Ph.D., has joined the company as Senior Vice President of Regulatory Affairs. Dr. Jackson will oversee all facets of Cubist’s Regulatory Affairs, providing oversight for all U.S. and international regulatory matters, including filings and interactions with regulatory authorities. Dr. Jackson will report to Steve Gilman, Ph.D., Cubist’s Executive Vice President of Research and Development and Chief Scientific Officer.